About Baird
Families & Individuals
Corporations & Institutions
Baird Research & Insights
Contact Us
Client Login
Individuals - Baird OnLine
Institutions
Corporations & Institutions
Investment Banking
M&A Recent Transactions
Deal Card
Investment Banking
Conferences
Asset Management
Private Equity
Fixed Income Sales and Trading
Equity Sales and Trading
Executive Services
Public Finance
Corporate Services
Institutional Consulting
Contact Us
Mergers and Acquisitions
Equity Financing
Corporate Restructuring
Industries of Focus
Financial Sponsors
Team Bios
News
Investment Banking Accolades
M&A Expertise
M&A Services
M&A Recent Transactions
Equity Financing Expertise
Equity Financing Services
Recent Financing Transactions
Corporate Restructuring Expertise
Corporate Restructuring Services
Business Services
Clean Technology
Consumer
Distribution
Energy
Financial Services
Healthcare
Industrial
Real Estate
Technology
Utilities
Financial Sponsors Recent Transactions
Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
November 2007
PharMEDium Healthcare Corporation
Recapitalization with Oak Investment Partners and Baird Private Equity
$200.0 Million
Robert W. Baird & Co. served as sole advisor
PharMEDium Healthcare Corp. (“PharMEDium”), the leading provider of outsourced pharmacy compounding services to hospitals, announced that Oak Investment Partners has invested in PharMEDium. Current investors Baird Capital Partners (BCP) and Baird Venture Partners (BVP) (collectively, “Baird Private Equity”) have sold a portion of their ownership but still retain a meaningful equity position in PharMEDium; David N. Jonas, the founder of the company, will retain his equity position. Terms of Oak Investment Partners, BCP and BVP’s investments were not disclosed.
PharMEDium is a national provider of pharmacy compounding services across multiple therapeutic classes and today services over 1,800 hospitals throughout the United States. Founded in 1992 as Compass Services by Baxter Healthcare Corp., the business unit was acquired by PharMEDium in 2003.
Oak Investment Partners is a multi-stage venture capital firm with a total of $8.4 billion in committed capital. The primary investment focus is on high growth opportunities in communications, information technology, internet new media, financial services information technology, healthcare services and consumer retail.
Baird Private Equity is a global private equity group that makes venture capital, change-in-control and growth equity investments in the United States through Baird Venture Partners and Baird Capital Partners and in Europe through Baird Capital Partners Europe and Granville Baird Ltd, an affiliated fund manager that invests in Germany. Baird Private Equity has raised and managed $2.2 billion in capital.
For additional information about this transaction, please contact:
Managing Director
(404) 240-5678
Managing Director
(312) 609-4913
Vice President
(414) 298-6162
Careers
|
Help
|
Site Map
|
Important Disclosures
|
Privacy Policy
|
Financial Information
|
Business Continuity
©2013 Robert W. Baird & Co. Incorporated.
Global Websites:
Europe
|
Asia
The services featured on this Web site may not be available in all jurisdictions or to all persons/entities. For more information, please see
Important Disclosures
. Robert W. Baird & Co. Incorporated. Member
SIPC
.